Form 483

MSKCC RMIPC Form 483, 2016-03-29

FDA issued a Form 483 to MSKCC RMIPC on 2016-03-29 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

MSKCC RMIPC · New York, United States · Issued March 29, 2016

Overview

  • 4 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

29 Mar 2016
21 CFR 212.30(b)

Equipment procedures overall

Cited by Jose O Hernandez, Rachael A Moliver, Charisse K Green

29 Mar 2016
21 CFR 212.30(b)

Equipment procedures overall

Cited by Jose O Hernandez, Rachael A Moliver, Charisse K Green

29 Mar 2016
21 CFR 212.40(a)

Suitable for intended use

Cited by Jose O Hernandez, Rachael A Moliver, Charisse K Green

29 Mar 2016
21 CFR 212.40(a)

Suitable for intended use

Cited by Jose O Hernandez, Rachael A Moliver, Charisse K Green

Inspected site

MRMSKCC RMIPCNew York, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 212.30(b)Cited across public-safe Form 483 observations2x
21 CFR 212.40(a)Cited across public-safe Form 483 observations2x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 4 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere